Trademark: 97146661
Word
NORGINE
Status Date
Tuesday, April 2, 2024
Filing Date
Monday, November 29, 2021
Published for Opposition
Tuesday, April 2, 2024
41 Educational services, namely, providing live and on-line classes, seminars, workshops in the field of medicine; Medical training and teaching; Teaching in the field of pharmaceutical products and medical conditions; Arranging and conducting of educational courses, seminars, workshops, conferences, symposiums in the field of medicine and medical science; Teaching services in the field of medicine
5 Pharmaceutical preparations, namely, laxatives, enema preparations, and intestinal lavage preparations; Pharmaceutical preparations for the diagnosis, prevention, alleviation and treatment of incontinence, gastroenterology conditions, pelvic disorders, respiratory conditions, hepatology conditions, hepatic encephalopathy, malignant hypothermia, gynaecological conditions and obstetrical conditions; Dietary supplements for human beings
36 Financial services, namely, investment fund transfer and transaction services, debt settlement; Credit and lending services, namely, money lending, credit agencies; Arranging financing for commercial companies; Provision of financing to health care companies; Venture capital financing; Fundraising services, namely, charitable fundraising, business fundraising for others; Financial sponsorship of cultural and sporting events
44 Medical information services; Provision of information in the medical field to health professionals and patients
10 Medical and surgical apparatus and instruments; Medical apparatus and instruments for treating gastrointestinal conditions and diseases; Medical apparatus and instruments for treating cancer; Diagnostic apparatus for medical use, namely, diagnostic apparatus for the diagnosis of gastrointestinal conditions and diseases; Medical diagnostic apparatus for the diagnosis of cancer; Enema apparatus for medical use
42 Scientific and technological services as well as research and design relating thereto, namely, conducting early evaluations in the field of new pharmaceuticals, scientific research; Research and development services in the pharmaceutical field; Provision of information relating to medical and scientific research in the field of pharmaceutical products and clinical trials
The mark consists of the dark blue wording "NORGINE" beneath a stylized sailboat design in dark blue, light blue and gray; the color white in the sails is background and not a feature of the mark.
The color(s) dark blue, light blue and gray is/are claimed as a feature of the mark.
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2024
Published For Opposition
Mar 29, 2024
Assigned To Examiner
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Feb 29, 2024
Approved For Pub - Principal Register
Feb 28, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 28, 2024
Assigned To Lie
Feb 28, 2024
Previous Allowance Count Withdrawn
Apr 13, 2023
Teas Voluntary Amendment Received
Sep 16, 2022
On Hold - Electronic Record Review Required
Sep 12, 2022
Approved For Pub - Principal Register
Sep 8, 2022
Assigned To Examiner
Jul 14, 2022
Teas Change Of Correspondence Received
Jul 14, 2022
Teas Change Of Domestic Representatives Address
Jul 14, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 14, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 29, 2021
Teas Amendment Entered Before Attorney Assigned
Dec 29, 2021
Teas Voluntary Amendment Received
Dec 3, 2021
Notice Of Design Search Code E-Mailed
Dec 2, 2021
New Application Office Supplied Data Entered
Dec 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
